Literature DB >> 15191688

The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians.

Günter Klöppel1, Jutta Lüttges.   

Abstract

The phenotypic classification of pancreatic neoplasms is based on their cellular lineage. Thus, tumors with a ductal, acinar, and endocrine phenotype can be distinguished. Most pancreatic neoplasms show a ductal phenotype and can be classified as ductal adenocarcinomas. Less common tumors with a ductal phenotype are the variants of ductal adenocarcinoma, intraductal papillary mucinous neoplasm (including colloid carcinoma), mucinous cystic neoplasm, medullary carcinoma, and other rare tumors. Ductal adenocarcinomas most likely develop from ductal proliferative lesions arising in the pancreatic duct system. A recently adopted classification system for these lesions distinguishes between three grades of pancreatic intraepithelial neoplasia (PanIN). Molecular studies have revealed that PanIN-2 and PanIN-3 lesions represent a distinct step toward invasive carcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15191688     DOI: 10.1007/s11894-004-0037-y

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  60 in total

Review 1.  Genetic progression in the pancreatic ducts.

Authors:  R H Hruban; R E Wilentz; S E Kern
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

Review 2.  Mixed exocrine-endocrine tumors of the pancreas.

Authors:  G Klöppel
Journal:  Semin Diagn Pathol       Date:  2000-05       Impact factor: 3.464

3.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

Review 4.  Familial pancreatic cancer: a review.

Authors:  H T Lynch; T Smyrk; S E Kern; R H Hruban; C J Lightdale; S J Lemon; J F Lynch; L R Fusaro; R M Fusaro; P Ghadirian
Journal:  Semin Oncol       Date:  1996-04       Impact factor: 4.929

5.  Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas.

Authors:  R E Wilentz; J Albores-Saavedra; M Zahurak; M A Talamini; C J Yeo; J L Cameron; R H Hruban
Journal:  Am J Surg Pathol       Date:  1999-11       Impact factor: 6.394

6.  Higher frequency of DPC4/Smad4 alterations in pancreatic cancer cell lines than in primary pancreatic adenocarcinomas.

Authors:  D Bartsch; P Barth; D Bastian; A Ramaswamy; B Gerdes; B Chaloupka; Y Deiss; B Simon; A Schudy
Journal:  Cancer Lett       Date:  1999-05-03       Impact factor: 8.679

7.  Progression of atypical ductal hyperplasia/carcinoma in situ of the pancreas to invasive adenocarcinoma.

Authors:  E Brockie; A Anand; J Albores-Saavedra
Journal:  Ann Diagn Pathol       Date:  1998-10       Impact factor: 2.090

8.  Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients.

Authors:  F Sessa; E Solcia; C Capella; M Bonato; A Scarpa; G Zamboni; N S Pellegata; G N Ranzani; F Rickaert; G Klöppel
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  BRCA2 germline mutations in familial pancreatic carcinoma.

Authors:  Stephan A Hahn; Bill Greenhalf; Ian Ellis; Mercedes Sina-Frey; Harald Rieder; Birgit Korte; Berthold Gerdes; Ralf Kress; Andreas Ziegler; John A Raeburn; Donata Campra; Robert Grützmann; Helga Rehder; Matthias Rothmund; Wolff Schmiegel; John P Neoptolemos; Detlef K Bartsch
Journal:  J Natl Cancer Inst       Date:  2003-02-05       Impact factor: 13.506

10.  Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays.

Authors:  Christine A Iacobuzio-Donahue; Anirban Maitra; Mari Olsen; Anson W Lowe; N Tjarda van Heek; Christophe Rosty; Kim Walter; Norihiro Sato; Antony Parker; Raheela Ashfaq; Elizabeth Jaffee; Byungwoo Ryu; Jessa Jones; James R Eshleman; Charles J Yeo; John L Cameron; Scott E Kern; Ralph H Hruban; Patrick O Brown; Michael Goggins
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

View more
  12 in total

1.  Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.

Authors:  Matthias Löhr; Günter Klöppel; Patrick Maisonneuve; Albert B Lowenfels; Jutta Lüttges
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

2.  Comparative analysis of clinicopathological correlations of cyclooxygenase-2 expression in resectable pancreatic cancer.

Authors:  Marketa Hermanova; Petr Karasek; Jiri Tomasek; Jiri Lenz; Jiri Jarkovsky; Petr Dite
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

3.  In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging.

Authors:  Stefan Eser; Marlena Messer; Philipp Eser; Alexander von Werder; Barbara Seidler; Monther Bajbouj; Roger Vogelmann; Alexander Meining; Johannes von Burstin; Hana Algül; Philipp Pagel; Angelika E Schnieke; Irene Esposito; Roland M Schmid; Günter Schneider; Dieter Saur
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

4.  [Pancreatic ductal adenocarcinoma and its precursors].

Authors:  J Lüttges; G Klöppel
Journal:  Pathologe       Date:  2005-02       Impact factor: 1.011

Review 5.  SMAD4 and its role in pancreatic cancer.

Authors:  Xiang Xia; Weidong Wu; Chen Huang; Gang Cen; Tao Jiang; Jun Cao; Kejian Huang; Zhengjun Qiu
Journal:  Tumour Biol       Date:  2014-12-03

6.  High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA and via HIF1a to HB-EGF and bFGF.

Authors:  Andreas-Claudius Hoffmann; Ryutaro Mori; Daniel Vallbohmer; Jan Brabender; Uta Drebber; Stephan E Baldus; Ellen Klein; Mizutomo Azuma; Ralf Metzger; Christina Hoffmann; Arnulf H Hoelscher; Kathleen D Danenberg; Klaus L Prenzel; Peter V Danenberg
Journal:  J Gastrointest Surg       Date:  2008-08-13       Impact factor: 3.452

7.  Upregulation and redistribution of integrin alpha6beta4 expression occurs at an early stage in pancreatic adenocarcinoma progression.

Authors:  Zobeida Cruz-Monserrate; Suimin Qiu; B Mark Evers; Kathleen L O'Connor
Journal:  Mod Pathol       Date:  2007-04-13       Impact factor: 7.842

8.  Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.

Authors:  Tatyana Kalinina; Cenap Güngör; Sabrina Thieltges; Maren Möller-Krull; Eva Maria Murga Penas; Daniel Wicklein; Thomas Streichert; Udo Schumacher; Viacheslav Kalinin; Ronald Simon; Benjamin Otto; Judith Dierlamm; Heidi Schwarzenbach; Katharina E Effenberger; Maximilian Bockhorn; Jakob R Izbicki; Emre F Yekebas
Journal:  BMC Cancer       Date:  2010-06-16       Impact factor: 4.430

9.  Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system.

Authors:  Johannes Fredebohm; Michael Boettcher; Christian Eisen; Matthias M Gaida; Anette Heller; Shereen Keleg; Jörg Tost; Karin M Greulich-Bode; Agnes Hotz-Wagenblatt; Mark Lathrop; Nathalia A Giese; Jörg D Hoheisel
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

10.  BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.

Authors:  Hany Kayed; Sandor Bekasi; Shereen Keleg; Christoph W Michalski; Thomas Giese; Helmut Friess; Jörg Kleeff
Journal:  Mol Cancer       Date:  2007-12-28       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.